Piramal Enterprises Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Piramal Enterprises Limited
Siggi Olafsson has taken the reins at Mallinckrodt after stepping down as Hikma’s CEO. At the same time, Teva has named a new global R&D and chief medical officer while Piramal Pharma Solutions has appointed a fresh COO and Formycon has added to its supervisory board.
Pfizer effects hundreds of field force job cuts in India as it rewires its commercialization approach and creates new roles leveraging its ‘digital core’, but industry experts suggest there is a complex mix of other factors at play as well.
Tapping into Abingworth’s pioneering clinical co-development model, the private equity behemoth is using that experience to form Launch Therapeutics which will seek to partner with biotech and biopharma on "best‐in‐class, late‐stage clinical assets [and] bring life‐saving therapies to market better, faster and cheaper."
Pharma in India draws on celebrity endorsement to spotlight specific disease conditions, with social media adding new dimensions to these efforts. But do these campaigns, now facing increasing disclosure scrutiny more widely, deliver a return on investment?
- Generic Drugs
- Drug Discovery Tools
- Other Names / Subsidiaries
- Ash Stevens Inc.
- Life Molecular Imaging
- Piramal Critical Care
- Piramal Enterprises Ltd.
- Piramal Healthcare, Ltd.
- Piramal Imaging SA
- Piramal Life Sciences, Ltd.
- Piramal Pharma Solutions